BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 24035042)

  • 1. Clinical implications of serial serum N-terminal prohormone brain natriuretic peptide levels in the prediction of outcome in children with dilated cardiomyopathy.
    Kim G; Lee OJ; Kang IS; Song J; Huh J
    Am J Cardiol; 2013 Nov; 112(9):1455-60. PubMed ID: 24035042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usefulness of Serial N-terminal Pro-B-type Natriuretic Peptide Measurements to Predict Cardiac Death in Acute and Chronic Dilated Cardiomyopathy in Children.
    den Boer SL; Rizopoulos D; du Marchie Sarvaas GJ; Backx AP; Ten Harkel AD; van Iperen GG; Rammeloo LA; Tanke RB; Boersma E; Helbing WA; Dalinghaus M
    Am J Cardiol; 2016 Dec; 118(11):1723-1729. PubMed ID: 27692597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NT-proBNP as a marker for persistent cardiac disease in children with history of dilated cardiomyopathy and myocarditis.
    Nasser N; Perles Z; Rein AJJT; Nir A
    Pediatr Cardiol; 2006; 27(1):87-90. PubMed ID: 16132296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-terminal pro brain natriuretic peptide to predict prognosis in dilated cardiomyopathy with sinus rhythm.
    Tigen K; Karaahmet T; Kahveci G; Tanalp AC; Bitigen A; Fotbolcu H; Bayrak F; Mutlu B; Basaran Y
    Heart Lung Circ; 2007 Aug; 16(4):290-4. PubMed ID: 17403613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma N-terminal protype-B natriuretic peptide levels in risk assessment of patients with mitral regurgitation secondary to ischemic and nonischemic dilated cardiomyopathy.
    Dini FL; Fontanive P; Conti U; Andreini D; Cabani E; De Tommasi SM
    Am Heart J; 2008 Jun; 155(6):1121-7. PubMed ID: 18513528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic utility of anemia and pro-B-type natriuretic peptide in patients with nonischemic dilated cardiomyopathy and normal renal function.
    Tigen K; Karaahmet T; Cevik C; Gurel E; Mutlu B; Basaran Y
    Am J Med Sci; 2009 Feb; 337(2):109-15. PubMed ID: 19214026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diagnostic value of plasma concentration of pro-brain natriuretic peptide in congestive heart failure in pediatric patients with ventricular septal defects].
    Wu YR; Chen SB; Huang MR; Zhang YQ; Sun K; Chen S
    Zhonghua Er Ke Za Zhi; 2005 Mar; 43(3):161-4. PubMed ID: 15833183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term prognostic value and serial changes of plasma N-terminal prohormone B-type natriuretic peptide in patients undergoing transcatheter aortic valve implantation.
    Ribeiro HB; Urena M; Le Ven F; Nombela-Franco L; Allende R; Clavel MA; Dahou A; Côté M; Laflamme J; Laflamme L; DeLarochellière H; DeLarochellière R; Doyle D; Dumont E; Bergeron S; Pibarot P; Rodés-Cabau J
    Am J Cardiol; 2014 Mar; 113(5):851-9. PubMed ID: 24528616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum N-terminal brain natriuretic peptide as a prognostic parameter in patients with pulmonary hypertension.
    Fijalkowska A; Kurzyna M; Torbicki A; Szewczyk G; Florczyk M; Pruszczyk P; Szturmowicz M
    Chest; 2006 May; 129(5):1313-21. PubMed ID: 16685024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NT-proBNP response to dobutamine stress echocardiography predicts left ventricular contractile reserve in dilated cardiomyopathy.
    Parthenakis FI; Patrianakos AP; Haritakis CN; Zacharis EA; Nyktari EG; Vardas PE
    Eur J Heart Fail; 2008 May; 10(5):475-81. PubMed ID: 18396456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Left ventricular cavity area reflects N-terminal pro-brain natriuretic peptide plasma levels in heart failure.
    Taléns-Visconti R; Rivera Otero M; Sancho-Tello MJ; de Burgos FG; Martínez-Dolz L; Sevilla B; Climent V; Cortés R; Salvador A; Sogorb F; Miro V; Valero R; Perez-Boscá JL; Bertomeu V; Portolés M; Payá R
    Eur J Echocardiogr; 2006 Jan; 7(1):45-52. PubMed ID: 15939671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization and prediction of natriuretic peptide "nonresponse" during heart failure management: results from the ProBNP Outpatient Tailored Chronic Heart Failure (PROTECT) and the NT-proBNP-Assisted Treatment to Lessen Serial Cardiac Readmissions and Death (BATTLESCARRED) study.
    Gaggin HK; Truong QA; Rehman SU; Mohammed AA; Bhardwaj A; Parks KA; Sullivan DA; Chen-Tournoux A; Moore SA; Richards AM; Troughton RW; Lainchbury JG; Weiner RB; Baggish AL; Semigran MJ; Januzzi JL
    Congest Heart Fail; 2013; 19(3):135-42. PubMed ID: 23279139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serial measurements of serum NT-proBNP as markers of left ventricular systolic function and remodeling in children with heart failure.
    Rusconi PG; Ludwig DA; Ratnasamy C; Mas R; Harmon WG; Colan SD; Lipshultz SE
    Am Heart J; 2010 Oct; 160(4):776-83. PubMed ID: 20934575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive value of B-type natriuretic peptides in detecting latent left ventricular diastolic dysfunction in beta-thalassemia major.
    Kremastinos DT; Hamodraka E; Parissis J; Tsiapras D; Dima K; Maisel A
    Am Heart J; 2010 Jan; 159(1):68-74. PubMed ID: 20102869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-terminal proBNP levels in patients with Chagas disease: a marker of systolic and diastolic dysfunction of the left ventricle.
    Barbosa MM; Nunes Mdo C; Ribeiro AL; Barral MM; Rocha MO
    Eur J Echocardiogr; 2007 Jun; 8(3):204-12. PubMed ID: 16651029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of N-terminal pro-brain natriuretic Peptide in outpatients with hypertrophic cardiomyopathy.
    D'Amato R; Tomberli B; Castelli G; Spoladore R; Girolami F; Fornaro A; Caldini A; Torricelli F; Camici P; Gensini GF; Cecchi F; Olivotto I
    Am J Cardiol; 2013 Oct; 112(8):1190-6. PubMed ID: 23871673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aminoterminal pro type B natriuretic peptide as a predictive and prognostic marker in patients with chronic heart failure.
    Rothenburger M; Wichter T; Schmid C; Stypmann J; Tjan TD; Berendes E; Etz C; Pioux A; Löher A; Wenzelburger F; Drees G; Hoffmeier A; Breithardt G; Scheld HH
    J Heart Lung Transplant; 2004 Oct; 23(10):1189-97. PubMed ID: 15477114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of N-terminal proBNP in the clinic scoring of heart failure due to dilated cardiomyopathy in children.
    Narin N; Hekimoglu B; Baykan A; Ozyurt A; Zararsiz G; Sezer S; Onan SH; Argun M; Pamukcu O; Uzum K
    Clin Lab; 2014; 60(4):563-70. PubMed ID: 24779290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma N-terminal pro-B-type natriuretic peptide as a predictor of perioperative and long-term outcome after vascular surgery.
    Schouten O; Hoeks SE; Goei D; Bax JJ; Verhagen HJ; Poldermans D
    J Vasc Surg; 2009 Feb; 49(2):435-41; discussion 441-2. PubMed ID: 19028043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic value of repeated measurement of N-terminal pro-B-type natriuretic peptide in patients with chronic heart failure due to left ventricular systolic dysfunction.
    Kubánek M; Goode KM; Lánská V; Clark AL; Cleland JG
    Eur J Heart Fail; 2009 Apr; 11(4):367-77. PubMed ID: 19179406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.